BLINK AG is a German-based startup that is revolutionizing the field of bioanalytics and diagnostics with their next-generation microfluidics-free digital PCR technology. Founded in 2015, BLINK AG's groundbreaking products, including the BLINK Beads, the BLINK X, and the BLINK One, empower scientists and clinicians to achieve rapid, ultra-sensitive digital multiplex assays for sample nucleic acid extraction, multiplex analysis, and quantification in a single compact workflow. This approach enables rapid molecular diagnostics, allowing for immediate, targeted therapy and ultimately leading to better patient outcomes and a more effective healthcare system. Their slogan, "A new era of diagnostics. Rapid, ultraplex, microfluidics-free digital PCR.", reflects their commitment to driving innovation in the Biotechnology and Health Care industries.
There is no investment information
No recent news or press coverage available for BLINK AG.